Market Overview

UPDATE: Quest Diagnostics Posts Higher Q4 Profit, Issues Downbeat 2014 Forecast

Related DGX
14 Healthcare Stocks Fundstrat Is Buying
Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer
DaVita (DVA) Introduces Medicare-Specific ACO in Arizona (Zacks)

Quest Diagnostics (NYSE: DGX) reported a rise in its fourth-quarter profit.

Quest expects 2014 earnings of $3.90 to $4.10 per share, versus analysts' estimates of $4.18 per share.

Quest's quarterly profit surged to $143 million, or $0.97 per share, from a year-ago profit of $56 million, or $0.34 per share. Excluding special items, Quest's earnings from continuing operations came in at $1.03 per share.

Its revenue fell 1% to $1.76 billion. However, analysts were projecting earnings of $0.93 per share on revenue of $1.74 billion.

The company's board also lifted its quarterly dividend by 10% to $0.33 per share.

Quest shares gained 0.99% to $54.33 in pre-market trading.

Posted-In: profitEarnings News Guidance


Related Articles (DGX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters